In prostate cancer, MAP3K7 is a putative tumor suppressor gene and MAP3K7 deletion has been shown to directly correlate with prostate cancer progression, lymph node metastasis, and biochemical recurrence [226,227]. This evidence concerns the gene MAP3K7 and Familial prostate cancer.